Hematologists Accepting Medicare in MassachusettsPage 2

Gabriela Hobbs, MD

Hematology

Margaret Shipp, MD

Chief of the Division of Hematologic Neoplasia at DFCI, the Director of the Lymphoma and Myeloma Program of the Dana-Farber/Harvard Cancer Center and a Pro; Chair in Lymphoma

Hematology

Nancy Berliner, MD

Chief, Division of Adult Hematology; Professor of Medicine, Harvard Medical School

Hematology

Andrew Hantel, M.D.

Assistant Professor of Medicine at Harvard Medical School and faculty member in the Divisions of Leukemia and Population Sciences at Dana-Farber Cancer Institute and the

Hematology

Raymond Comenzo, MD

Professor of Medicine, Tufts University School of Medicine; Medical Director, Blood Bank, Cell Therapy Lab and Apheresis Center; John C. Davis Myeloma and Amyloid Program

Hematology

Larissa Bornikova, M.D.

Hematology

Steven McAfee, MD

Hematology

Jeffrey Barnes, M.D., PH.D

Hematology

Noopur Raje, MD

Director, Center for Multiple Myeloma, Mass General; Professor of Medicine, Harvard Medical School

Hematology

Andrew Branagan, M.D.

Attending Physician

Hematology

Sean Mullally, M.D.

Hematology

Ibiayi Dagogo-Jack, M.D.

Associate Professor of Medicine, Harvard Medical School; Director of Molecular Testing Integration, Mesothelioma Program Leader, Massachusetts General Hospital

Hematology

Ilyas Sahin, MD

Instructor in Medicine, Harvard Medical School

Hematology

Richard Stone, D.C.

Director of the Adult Acute Leukemia Program at DFCI, serves on the Medical Oncology Board of the American Board of Internal Medicine, and is vice chair of th; Chief of Staff

Hematology

Bradley McGregor, MD

Director of Clinical Research for the Lank Center of Genitourinary Oncology serving as a Medical Oncologist specializing in genitourinary malignancies at the; Director of Clinical Research, Lank Center for Genitourinary Oncology

Hematology

Katayoon Goodarzi, M.D.

Hematology

Rupa Narayan, MD

Hematology

Antonio Giordano, M.D., PH.D

Clinical Director, Center for Cancer Therapeutic Innovation; Breast Cancer Pathways Medical Director, Dana-Farber Cancer Institute

Hematology

Jennifer Faig, M.D.

Hematology

James Cleary, MD/PHD

Associate Professor of Medicine, Harvard Medical School; Co-Director of Clinical Trials, Center for Gastrointestinal Oncology, Dana-Farber Cancer Institute

Hematology